Ascend Wellness Holdings (AAWH) Deferred Taxes (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Deferred Taxes of -$2.4 million for Q1 2026, up 22.02% year-over-year from -$2.0 million in Q1 2025, and down 423.88% quarter-over-quarter from $737000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Deferred Taxes (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Deferred Taxes history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 22.02% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$7.3 million (up 39.56% YoY), while the FY2025 annual figure was -$8.0 million, up 35.1% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$2.4 million, down from $737000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $737000.0 in Q4 2025, with the low at -$6.5 million in Q3 2023.
- The 5-year median for Deferred Taxes is -$2.2 million (2024), against an average of -$2.4 million.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes plunged 306.64% in 2023, then soared 134.62% in 2025.
- Ascend Wellness Holdings' Deferred Taxes stood at -$2.0 million in 2022, then soared by 32.27% to -$1.4 million in 2023, then plunged by 54.84% to -$2.1 million in 2024, then soared by 134.62% to $737000.0 in 2025, then slumped by 423.88% to -$2.4 million in 2026.
- Business Quant data shows AAWH's Deferred Taxes at -$2.4 million in Q1 2026, $737000.0 in Q4 2025, and -$3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.40 Mn |
| Mar 31, 2026 | -2.39 Mn |
| Dec 31, 2025 | 737,000.00 |
| Sep 30, 2025 | -3.06 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | -2.21 Mn |
| Mar 31, 2024 | -3.27 Mn |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -2.22 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | -981,000.00 |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2021 | -1.75 Mn |
| Sep 30, 2021 | -833,000.00 |